Outcomes in children with Clostridium difficile infection: results from a nationwide survey

Arjun Gupta1,2, Darrell S Pardi3, Larry M Baddour1

  • 1Divisions of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.

Insights

Clostridium difficile infection (CDI) significantly impacts hospitalized children, leading to longer hospital stays, increased colectomy rates, higher mortality, and more frequent discharge to care facilities. These adverse outcomes highlight the persistent challenge of CDI in pediatric populations.

Area of Science:

  • Pediatric infectious diseases
  • Hospital epidemiology
  • Public health surveillance

Background:

  • Clostridium difficile infection (CDI) incidence is rising in both adults and children.
  • Outcomes for pediatric CDI cases are not well understood.
  • Hospitalized children represent a vulnerable population for CDI.

Purpose of the Study:

  • To analyze the incidence and outcomes of CDI in hospitalized children using national data.
  • To identify associations between CDI and key adverse health outcomes in pediatric patients.
  • To understand the impact of CDI on length of stay, colectomy, mortality, and discharge disposition.

Main Methods:

  • Utilized United States National Hospital Discharge Survey (NHDS) data from 2005-2009.
  • Identified CDI cases and comorbidities using ICD-9 codes.
  • Performed weighted univariate and multivariate analyses to assess incidence and outcomes.

Main Results:

  • An estimated 46,176 pediatric patients had CDI, with an overall incidence of 33.5 per 10,000 hospitalizations.
  • CDI was independently associated with significantly increased length of stay (6.4 days), colectomy (OR 2.1), mortality (OR 2.3), and discharge to a care facility (OR 1.7).
  • These associations remained significant even after adjusting for age, sex, and comorbidities.

Conclusions:

  • CDI is a significant issue in hospitalized children, despite increased awareness and improved management.
  • Pediatric CDI is strongly linked to adverse outcomes including prolonged hospitalization, surgical intervention (colectomy), in-hospital death, and need for post-discharge care.
  • Further research and preventative strategies are warranted to mitigate the impact of CDI in pediatric patients.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
9
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
10
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
531
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
829